In the latest example of the Trump administration’s and new U.S. Attorney General Jeff Sessions’ increased focus on the illicit drug trade, the U.S. Department of Justice has announced the formation of a unit designed to combat opioid-related health care fraud.
The Opioid Fraud and Abuse Detection Unit will rely on data to identify and prosecute individuals and companies that contribute to the opioid prescription and heroin addiction epidemic plaguing the country. The unit’s targets will include physicians and other providers who operate pill mills and pharmacies that illegally dispense or divert prescriptions for the dangerously addictive pain killers. Most of the program’s initial districts are in the Midwest and Southern states.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
